These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1292713)

  • 1. Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria.
    Zhang Y; Wallace RJ; Steingrube VA; Brown BA; Nash R; Silcox A; Tsukamura M
    Tuber Lung Dis; 1992 Dec; 73(6):337-44. PubMed ID: 1292713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance.
    Wallace RJ; Nash DR; Udou T; Steingrube VA; Steele LC; Swenson JM; Silcox VA
    Am Rev Respir Dis; 1985 Nov; 132(5):1093-7. PubMed ID: 3877482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
    Kwon HH; Tomioka H; Saito H
    Tuber Lung Dis; 1995 Apr; 76(2):141-8. PubMed ID: 7780097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility.
    Nash DR; Wallace RJ; Steingrube VA; Udou T; Steele LC; Forrester GD
    Am Rev Respir Dis; 1986 Dec; 134(6):1276-82. PubMed ID: 3491556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.
    Wallace RJ; Brown BA; Silcox VA; Tsukamura M; Nash DR; Steele LC; Steingrube VA; Smith J; Sumter G; Zhang YS
    J Infect Dis; 1991 Mar; 163(3):598-603. PubMed ID: 1995732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoelectric focusing studies on Mycobacterium chelonei.
    Sparks J; Ross GW
    Tubercle; 1981 Dec; 62(4):289-93. PubMed ID: 6977905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Numerical classification of rapidly growing nonphotochromogenic mycobacteria.
    Tsukamura M; Ichiyama S
    Microbiol Immunol; 1986; 30(9):863-82. PubMed ID: 3796320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov.
    Kusunoki S; Ezaki T
    Int J Syst Bacteriol; 1992 Apr; 42(2):240-5. PubMed ID: 1581184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotaxonomic analysis of glycolipids from Mycobacterium chelonae-M. fortuitum complex and bovine farcy strains.
    Hamid ME; Ridell M; Minnikin DE; Goodfellow M
    Zentralbl Bakteriol; 1998 Jul; 288(1):23-34. PubMed ID: 9728402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoenzymes as tools to discriminate various subdivisions in the Mycobacterium fortuitum complex.
    Blom-Potar MC; David HL; Rastogi N
    Acta Leprol; 1989; 7 Suppl 1():39-43. PubMed ID: 2548363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.
    Steingrube VA; Gibson JL; Brown BA; Zhang Y; Wilson RW; Rajagopalan M; Wallace RJ
    J Clin Microbiol; 1995 Jan; 33(1):149-53. PubMed ID: 7699032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobactin analysis as an aid for the identification of Mycobacterium fortuitum and Mycobacterium chelonae subspecies.
    Bosne S; Lévy-Frébault VV
    J Clin Microbiol; 1992 May; 30(5):1225-31. PubMed ID: 1583124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamase activity in mycobacteria other than M. tuberculosis.
    Coira A; Salvadó M; Reig R; Chaves J; Segura C
    J Chemother; 1995 Apr; 7(2):106-8. PubMed ID: 7666114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae.
    Steele LC; Wallace RJ
    J Clin Microbiol; 1987 Feb; 25(2):456-7. PubMed ID: 3818939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.
    Brown-Elliott BA; Wallace RJ
    Clin Microbiol Rev; 2002 Oct; 15(4):716-46. PubMed ID: 12364376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors and inactivators of beta-lactamase from Mycobacterium fortuitum.
    Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Di Marzio L; Oratore A; Orefici G
    J Chemother; 1989 Oct; 1(5):293-7. PubMed ID: 2585031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of linezolid against rapidly growing mycobacteria.
    Wallace RJ; Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW
    Antimicrob Agents Chemother; 2001 Mar; 45(3):764-7. PubMed ID: 11181357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
    BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
    Nash DR; Wallace RJ; Steingrube VA; Shurin PA
    Drugs; 1986; 31 Suppl 3():48-54. PubMed ID: 3488197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobactins as chemotaxonomic characters for some rapidly growing mycobacteria.
    Hall RM; Ratledge C
    J Gen Microbiol; 1984 Aug; 130(8):1883-92. PubMed ID: 6470673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.